Benzoyl Peroxide Gel
NDC Package 45802-101-96
Package Information
Benzoyl Peroxide gel is a medication used to treat mild to moderate acne. This formulation utilizes a gel delivery system. Marketed by Padagis Israel Pharmaceuticals Ltd, this product is identified by NDC 45802-101 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 308689 - benzoyl peroxide 2.5 % Topical Gel
- RxCUI: 308689 - benzoyl peroxide 0.025 MG/MG Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45802 - Padagis Israel Pharmaceuticals Ltd
- 45802-101 - Benzoyl Peroxide
- 45802-101-96 - 1 TUBE in 1 CARTON / 60 g in 1 TUBE
- 45802-101 - Benzoyl Peroxide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45802-101-96 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Benzoyl Peroxide, a human over the counter drug labeled by Padagis Israel Pharmaceuticals Ltd. This gel is formulated for topical use and contains benzoyl peroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Israel Pharmaceuticals Ltd on March 13, 2012. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat mild to moderate acne. It may be used in combination with other acne treatments. When applied to the skin, benzoyl peroxide works by reducing the amount of acne-causing bacteria and by causing the skin to dry and peel. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
How is this Padagis Israel Pharmaceuticals Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802010196. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.